CXCL12 and bladder transitional cell carcinoma: in silico analyses (GEO, TCGA, ONCOMINE and UALCAN) showed that CXCL12 was significantly decreased in BlCa samples, comparing with the controls (Sun et al., 2021b; Du et al., 2021c).